Home / Intelligence / Scientific Publications / U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
Prader-Willi syndrome (PWS) is a complex developmental genetic disorder associated with hypotonia, poor feeding in neonates, onset of hyperphagia in early childhood, and shorter overall life expectancy. Prior epidemiology studies of PWS have examined smaller populations, with limited research in a US population. The aim of this study was to provide a contemporary estimate of PWS prevalence and annual all-cause mortality in the US using a large administrative medical claims dataset.
Authors
Shawn McCandless, Marissa Suh, David Yin, Michael Yeh, Shawn Czado, Sina Aghsaei, Justin Li, Kevin Francis, Nandini Hadker, Diane Stafford
Journal
Journal of the Endocrine Society; Volume 4; Issue Supplement_1; April-May 2020
Related Intelligence
Webinars
IC Administration Simplified
March 5, 2025 | 12:00 – 12:30 PM ET
Are you ready to take a bite out of IC administration complexity? Nothing demotivates a sales team like delayed or inaccurate incentive compensation (IC) calculations and payouts. While administering an IC plan may seem simple to outsiders, seasoned IC administrators know that’s not the case. It takes laser-focused attention to detail and timeliness to manage […]
Sign Up Now
Blog
Are Pharma Brands Really Transformational?
How can pharma brands connect digital marketing experiences to achieve truly transformational customer engagement? Brands that are leading the way demonstrate a complete grasp of fundamental digital marketing concepts and drive innovation in the ways that they engage customers. These brands maintain consistency in their message and interactions but tailor them to customer specific needs—and […]
Read More
Webinars
Navigating the Early Asset Evaluation Journey with Confidence
February 25, 2025 | 1:00 – 1:45 PM ET
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle. Join a team of cross-functional experts for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives.
Sign Up Now